Bill Snyder Archive — Page 1 of 118
-
April 23, 2026
Vanderbilt Health: A case study in achieving a lasting culture change
How can health care organizations implement impactful and long-lasting culture change that will meet patients’ expectations and improve their experience? -
April 22, 2026
Liquid biopsy predicts response to breast cancer immunotherapy
This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers reported April 22 in the journal Science Translational Medicine. -
April 21, 2026
Vanderbilt mourns Daryl Granner, leader of diabetes research and training
A former department chair and director of the Vanderbilt Diabetes Center, Dr. Granner made major contributions to understanding how insulin and glucocorticoids regulate genes that are important for glucose metabolism. -
April 20, 2026
Drug lifts ‘brain fog’ from lupus patients: Clinical trial
An estimated 200,000 people in the United States have lupus. About 80% of them experience “brain fog,” cognitive problems that impair learning, memory and attention. -
April 14, 2026
Genomic testing finds a higher prevalence of high-risk breast cancer in Black women
These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence. -
April 7, 2026
Multi-institutional team pioneers retinal test for early Alzheimer’s disease
The potential for a retinal screening test was bolstered by a recent discovery that clearance of amyloid-beta oligomers by immune cells in retinal blood vessels was disrupted in donor eyes from individuals with Alzheimer’s disease, compared to age-matched, healthy control eyes.